Understanding the Numbers: How many people are non-responders to semaglutide?
•
5 min read
Clinical trial data from the STEP program indicates that approximately 10-17% of individuals who take semaglutide are considered non-responders, achieving less than 5% body weight loss. This statistic underscores that while the medication is highly effective for many, there is significant variability in treatment outcomes, a crucial aspect for patients and healthcare providers to understand when considering therapy.
